LGALS1 and central nervous system cancer: Additionally, in a mouse glioma model, Gal-1-deficient tumor cells could be eradicated by host NK cells even before the initiation of an anti-tumor T cell response, suggesting that glioma cell-derived Gal-1 suppresses NK cell immune surveillance [171].